ARDELYX, INC. Deferred Tax Assets, Operating Loss Carryforwards
ARDELYX, INC. (ARDX) had Deferred Tax Assets, Operating Loss Carryforwards of $124.10 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $124.10M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $103.64M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $98.70M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $86.55M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $124.10M 10-K · filed 2026-02-19 |
| 2024-12-31 | $103.64M 10-K · filed 2026-02-19 |
| 2023-12-31 | $98.70M 10-K · filed 2025-02-20 |
| 2022-12-31 | $86.55M 10-K · filed 2024-02-22 |
| 2021-12-31 | $74.99M 10-K · filed 2023-03-02 |
| 2020-12-31 | $53.44M 10-K · filed 2022-02-28 |
| 2019-12-31 | $40.90M 10-K · filed 2021-03-08 |
| 2018-12-31 | $31.62M 10-K · filed 2020-03-06 |
| 2017-12-31 | $22.36M 10-K · filed 2019-03-06 |
| 2016-12-31 | $68.64M 10-K · filed 2018-03-14 |
| 2015-12-31 | $30.57M 10-K · filed 2017-02-17 |
| 2014-12-31 | $11.26M 10-K · filed 2016-03-04 |
| 2013-12-31 | $13.07M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |